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ABSTRACT
Adipose tissue macrophages (ATMs) are pivotal regulators for adipose tissue
function, specifically contributing to the homeostasis of the adipose niche. Signifi-
cantly increased ATMs and their altered activation patterns are causal factors to the
pathogenesis of adipose tissue inflammation, and subsequently, obesity associated
cardiovascular risks, type II diabetes and other metabolic syndromes. Macrophages
primarily display an anti-inflammatory M2 status in lean adipose tissues whereas
a proinflammatory M1 state in adipose tissues of obese individuals. Modulatory
networks governing ATMs polarized activation have been investigated but the full
picture remains vague. To understand the genome wide signaling networks in con-
trolling ATM polarization, we generated transcriptome profiles from macrophages
with various activation statuses- M0, M1 and M2. Among 23400 aligned unique loci
from the RNA-sequencing results, around 3500 displayed differential expression pat-
tern during macrophage polarization. The most enriched Gene Ontology terms in
the category of KEGG pathways are allograft rejection and Type I diabetes mellitus
pathways in M1 macrophages. IFNg was found to be one of the top upstream reg-
ulator in M1 playing pivotal role in different functional pathways. In addition, the
anti-inflammatory regulator miR-223 was found to be one of top upstream regulator
in M2 datasets and playing role in important functional pathways.Understanding of
the complex network of interactions among different factors involved in state of po-
larization of macrophages would be of great advantage in finding solutions to major
health issues.
ii
DEDICATION
To my family, friends and my beloved Lord
iii
ACKNOWLEDGEMENTS
Foremost, I would like to express my sincere gratitude to my advisor Dr. Beiyan
Zhou for her continuous support during my graduate study and research, for her
patience, motivation, enthusiasm, and immense knowledge. Her guidance helped me
in all the time of research and writing of this thesis. One simply could not wish for
a better or friendlier supervisor. I could not have imagined having a better advisor
and mentor for my research study.
I am also very graeful to Kranti Konganti who guided me through the whole
process of my data analyses. He was of a great support. My sincere thanks also
go to Yvonne, Cathy and Kim for helping me to understand rules and regulations,
and alerting me all times to meet my deadlines.I also would like to thank NIH who
provided funds for my research. I would like to speacially thanks MIT for sequencing
and providing me the datasets.
The College of Veterinary Medicine has provided the support and equipment I
have needed to produce and complete my thesis. My sincere thanks also goes to Dr.
John N. Stallone, Head of Department, for offering me the project opportunities in
their groups.
In my daily work I have been blessed with a friendly and cheerful group of fellow
students. I thank my fellow labmates Eddie, Richard, Haiqing, Hui, Hanna, Andrew,
Alzahra and all my colleagues for the stimulating discussions, for the sleepless nights
we were working together before deadlines, and for all the fun we have had. I also
would like to thank my friends especially Ayush, Atin, Krishna, Nikhil and Shraddha,
and enemies who criticized me and supported me to make myself better.
Last but not the least, I would like to thank my family: my parents Rajaiah and
iv
Pushpa Latha, for giving birth to me at the first place and also my sisters Kiran and
Indira , my brother Raviteja and my sweetest niece Hemanya and nephew Prithvi
for supporting me spiritually throughout my life.
v
TABLE OF CONTENTS
Page
ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ii
DEDICATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iii
ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . iv
TABLE OF CONTENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vi
LIST OF FIGURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . viii
LIST OF TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . x
1. INTRODUCTION AND REVIEW OF LITERATURE . . . . . . . . . . . 1
1.1 Macrophage Polarization and Its Diverse Functions . . . . . . . . . . 2
1.2 Adipose Tissue Macrophages (ATMs) are Major Contributors to Obe-
sity Associated Inflammation . . . . . . . . . . . . . . . . . . . . . . 4
1.3 MicroRNAs are Important for Adipose Tissue Function . . . . . . . . 6
1.4 Significance of MicroRNAs in Regulating Adipose Tissue Macrophage
Activation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
1.5 Transcriptional Profiling of Macrophage Polarization . . . . . . . . . 9
2. MATERIALS AND METHODS . . . . . . . . . . . . . . . . . . . . . . . . 11
2.1 Bone Marrow Isolation and Macrophage Differentiation . . . . . . . . 11
2.2 Macrophage Polarization . . . . . . . . . . . . . . . . . . . . . . . . 11
2.3 Next Generation Sequencing Data Processing . . . . . . . . . . . . . 12
2.4 Gene Ontology Analyses . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.5 RT-qPCR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15
2.6 Data and Statistical Analyses . . . . . . . . . . . . . . . . . . . . . . 15
3. RESULT AND DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . 16
3.1 Transcriptomic Analyses Revealed Almost Similar Number of Gene
Expression . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
3.2 M1 Vs M2 Macrophages Have More Number of Differentially Ex-
pressed Genes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
vi
3.3 Crosstalk Between Signaling Pathways . . . . . . . . . . . . . . . . . 29
3.4 Role of M1 in Diabetes Type I Mellitus is Signified by High Expression
of PPARG and IGF2bp2 . . . . . . . . . . . . . . . . . . . . . . . . . 35
3.5 High Expression of CIITA and TAP Genes Shows Role of M1 in Anti-
gen Presentation Pathway . . . . . . . . . . . . . . . . . . . . . . . . 35
3.6 Genes Related to Atherosclerosis Signaling are Highly Expressed in M2 36
3.7 Regulation of Expression by IFN-Gamma Play Important Role in Al-
lograft Rejection and Antigen Presentation . . . . . . . . . . . . . . . 37
3.8 LPS Induces Genes Responsible for Cellular Immune and Humoral
Response . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.9 IL4 Aids in THh1 Response . . . . . . . . . . . . . . . . . . . . . . . 39
3.10 Genes and Pathways Induced Through IL13 . . . . . . . . . . . . . . 40
3.11 Interaction Between IL4, IL13 and IFNG . . . . . . . . . . . . . . . . 41
4. CONCLUSION AND FUTURE PROSPECTS . . . . . . . . . . . . . . . . 42
REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
vii
LIST OF FIGURES
FIGURE Page
1.1 Classical and Alternative Activation In Macrophages. . . . . . . . . . 2
2.1 Experimental Design for In-vitro Macrophage Polarization . . . . . . 12
2.2 RNA-Sequencing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
3.1 RNA-Seq Bioinformatics Analysis Workflow . . . . . . . . . . . . . . 18
3.2 Intensity and Total Number of Expressed Genes are Comparable in
Macrophages at Various Activation Status . . . . . . . . . . . . . . . 19
3.3 Distribution of Expression Pattern of Genes Based on FPKM . . . . 20
3.4 MA Plot Visualizing the Values of M1, M2 and M0 Genes Compared
to Each Other . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21
3.5 Cluster Analysis of Differentially Expressed Genes . . . . . . . . . . . 22
3.6 Differentially Expressed Genes Among M0, M1 and M2 Macrophages 24
3.7 Regression Profiles Signify That M2 and M0 Macrophages Have a Very
High R Square Values . . . . . . . . . . . . . . . . . . . . . . . . . . 24
3.8 Cluster Analysis of Differentially Expressed mRNAs . . . . . . . . . . 25
3.9 Analysis of Protein Coding Genes . . . . . . . . . . . . . . . . . . . . 26
3.10 Genes Expressed More than 100 FPKM . . . . . . . . . . . . . . . . . 28
3.11 Validation of RNA Seq Data for Certain Genes Using qPCR . . . . . 28
3.12 Gene Ontology Analysis for Genes with More than 2 Folds Alteration
During Macrophage Polarization . . . . . . . . . . . . . . . . . . . . . 30
3.13 Significantly Enriched GO Terms in M1 or M2 Activation . . . . . . . 32
3.14 MiR223 Regulates Different Genes Which Impact Various Functional
Pathways . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
viii
3.15 IFNg- One of the Top Upstream Regulator . . . . . . . . . . . . . . . 38
3.16 IFNG, IL4 and IL13 Interaction Pattern . . . . . . . . . . . . . . . . 41
ix
LIST OF TABLES
TABLE Page
3.1 MM10 Reference Database . . . . . . . . . . . . . . . . . . . . . . . . 16
3.2 95% of RNA Sequencing Reads Mapped . . . . . . . . . . . . . . . . 17
3.3 Genes are Considered Expressed with FPKM Value Greater than 0.05 19
3.4 Differentially Expressed Genes Among M0, M1 and M2 . . . . . . . . 23
3.5 Analysis of Protein Coding Genes . . . . . . . . . . . . . . . . . . . . 26
3.6 Differential Expression Pattern of mRNAs . . . . . . . . . . . . . . . 27
3.7 M1 IPA Analyses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
3.8 M2 IPA Analyses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
x
1. INTRODUCTION AND REVIEW OF LITERATURE ∗
In the last several decades, lack of balanced diet both in terms of quality and
quantity has led to a rapid progression of obesity throughout the world; resulting in
a major pandemic situation attracting the attention of many nations. The severity
of obesity has been associated with many chronic diseases. Obese patients are prone
to conditions like inflammation and insulin resistance which are causal factors in the
pathogenesis of life threatening diseases like Type II Diabetes Mellitus, cardiovascu-
lar diseases and many more [1, 2, 3]. Recent studies have demonstrated that obesity
is a disease status characterized as chronic, low-degree tissue inflammations, which
can result from elevated infiltration of macrophages into obese tissues, and more im-
portantly, activation status shifts from an anti-inflammatory to a proinflammatory
status [1, 4, 5, 6, 7, 8, 9]. Impairment in the immune system makes it more difficult to
treat these disease conditions. Macrophages are key cellular components in the innate
immune system. They play an essential role in responding to invading pathogens by
triggering elaborate immuno-inflammatory reactions that ultimately results in the
elimination of the pathogen and reinstatement of normal conditions. In response to
microenvironmental cues like pathogenic and tissue-derived molecules, macrophages
undergo profound phenotypic changes and provide appropriate responses by adapt-
ing to their microenvironment [4, 10, 11]. Understanding these adaptive changes’
will provide pivotal information to open the gate for development of new clinical
therapies for treating chronic diseases within the proper context. Recent studies
have shown that microRNAs have a profound influence on immune cell functions,
including macrophage activation [12, 13].
∗Reprinted with permission from S Kanameni, W Ying and B Zhou. Mir223- a Potent Regulator
of Macrophage Polarization. J Nutr Food Sci, 3, 2013. Copyright 2013 Omics Publishing Group.
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1.1 Macrophage Polarization and Its Diverse Functions
Macrophages play several pivotal roles in innate and adaptive immune response,
tissue repair and remodeling and many more. Of the many key traits of macrophages,
a major one is their functional diversity [14, 15]. This key feature could be attributed
to their capability of responding to diverse stimuli and in turn exhibit diverse phe-
notypes and functional roles. Macrophages undergo two unique activation programs,
classical (M1) and alternate (M2) activation, and a full spectrum of intermediate
phenotypes between those two extremes in status [10, 14, 15]. In response to stim-
Figure 1.1: Classical and Alternative Activation In Macrophages.Schematic represen-
tation of classical versus alternative activation of macrophages depicting the stimuli,
their effects on cellular function, and surrounding tissue physiology. Proinflammatory
M1 macrophages contribute to bactericydal activity and production of inflammatory
cytokines. Antiinflammatory M2 with induced arginase levels is a crucial component
for tissue repair and angiogenesis.
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uli provided by bacterial infections like lipopolysaccharide (LPS) and interferon-γ
(IFN-γ), or palmitate fatty acid in the context of obesity, macrophages adopt a
classical activation strategy and a proinflammatory phenotype and become highly
phagocytotic, as well as exerting the bactericidal activity, and secreting proinflam-
matory cytokines and chemokines to further protect against invading pathogens. On
the other hand, signals from interleukins(IL) like IL-4 and IL-13 promote alternative
activation of macrophages which have role in parasite elimination, tissue remodeling
and repair, and inhibition of tumor progression [6, 14, 16, 17] [Fig 1.1]. The phe-
nomenon of activation of M1 and M2 macrophage polarization has been investigated
intensively in recent decades as it could lead into pathways for treatment of many
important disease conditions.
Genomic and transcriptional studies, and other phenotypic analyzes of M1 and
M2 macrophages provided immense knowledge on several distinct characteristics ex-
tending from traits inherent in their chemokinome to metabolome [18]. For exam-
ple, M1 macrophages express the Th1-attracting chemokines such as Chemokine
(C-X-C Motif) Ligand 9 (CXCL9) and CXCL10, whereas M2 macrophages express
the chemokines Chemokine (C-C Motif) Ligand 17 (CCL17), CCL22 and CCL24
[10, 18, 19, 20, 21, 22, 23]. In the same fashion, M1 and M2 macrophages dis-
play different functional phenotypes in response to glucose, amino acid, lipid and
iron metabolism [10, 14, 15]. Even though the macrophage polarization was studied
and defined in vitro using conventional methods, numerous studies have shown such
polarization states in vivo, under physiological and pathological conditions. Of a
note, macrophages stimulated in response to parasite infection, allergy and many
tumor types resemble a large extent an M2-or M2-like phenotype [24, 25]. But it
is to be considered that, in vivo conditions are often complex to interpret as other
cues involved both M1 and M2 macrophages which may show a mixture of multi-
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ple functional phenotypes [4, 17, 26]. Further, many study that cues which induce
polarization in vivo are due to interactions among various immune and non-immune
cell types like lymphocytes, dendritic cells, fibroblasts, and mesenchymal stem cells
[7, 10, 17, 27] and several other factors including non-coding Ribonucleic acids (ncR-
NAs) [28, 29, 30]. These factors make the study on macrophage polarization in
relation to these diverse cell types important. As mentioned, macrophages show func-
tional diversity ranging from inflammation, phagocytosis, immunoregulation, tissue
remodeling and even metabolism. The contribution of macrophages to inflammation
is one of its most well-documented functions. In contrast to its pro-inflammatory
functions, macrophages also contribute to the dampening of inflammation through
their immunoregulatory properties [15, 31, 32]. Phagocytosis is a defining feature
of macrophages. Macrophages not only play roles in killing pathogens but also in
the elimination of dead cells and remnants of cells that is important for resolution
of inflammation. In fact, it is known that phagocytosis of apoptotic cells polarizes
these cells into an anti-inflammatory mode that supports their immunoregulatory
functions [33].
1.2 Adipose Tissue Macrophages (ATMs) are Major Contributors to Obesity
Associated Inflammation
The central feature of obesity which aggravates the progression of insulin re-
sistance is chronic low-grade inflammation due to the infiltration of adipose tissue
by macrophages [1, 4]. The dysfunction of adipose tissue with respect to main-
taining energy homeostasis is associated with obesity, inflammation and metabolic
complications [34]. In addition, in the case of obese people, weight loss is linked
to improved insulin sensitivity and their risk of cardiovascular diseases is decreased.
The inflammatory condition in obese patients is different from inflammation caused
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by classical activated macrophages which are stimulated by pathogens. In response
to nutrient excess and its relatively chronic in nature, adipose tissue in obese indi-
viduals has an enhanced production of pro-inflammatory cytokines, infiltration by
immune related cells, especially ATMs and the formation of crown like structures
where apoptotic or soon to be apoptotic adipocytes and their remnants accumulate
and cluster around phagocytic macrophages [5, 35, 36]. In lean mice, the ATMs
are mainly the alternatively activated M2 macrophages and when these mice were
subjected to high fat diet there is seen a phenotypic switch in macrophage polar-
ization towards a pro-inflammatory type in mouse adipose tissue [27]. Polarized
macrophages play an important role in lipid metabolism and homeostasis. Studies
showed ATMs from tissues of lean subjects and ATMs during weight loss to resemble
M2 macrophage and found to express high levels of the anti-inflammatory cytokine
IL-10 [19, 37, 38]. It is believed that these ATMs maintain adipose tissue home-
ostasis by protecting from inflammation in response to high-fat concentrations [39].
As explained, obesity is associated with increased accumulation of macrophages as
well as with enhanced switching in polarization of ATMs from an anti-inflammatory
(M2) to a pro-inflammatory (M1) state [6]. This change in polarization could be re-
lated to pathogen interference and could be specified by the targeted grouping of M1
macrophages around adipocytes that are apoptotic and having necrotic like struc-
tures [40]. Interestingly, some studies suggested that in people who are experiencing
weight loss, there is a reduction in the infiltration of inflammatory macrophages into
the adipose tissue and an improvement in the inflammatory response and oxidant
profile of adipocytes as well as the circulating monocytes[30].
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1.3 MicroRNAs are Important for Adipose Tissue Function
Compelling evidence suggested critical roles of microRNAs in regulating adi-
pose tissue function in the context of obesity [41]. The discovery of microRNAs,
a class of 21-23-nucleotide non-coding RNAs revealed a new layer of gene regula-
tion in almost every aspect of biological processes, including those of the immune
systems [12, 13]. MicroRNAs are short non-coding RNAs that are approximately
22-nucleotide in length and bind to target messenger RNAs (mRNAs) and regu-
late gene expression. The microRNA pairs to its target mRNAs typically result in
their degradation and/or repression of translation [42]. MicroRNAs are expressed
in a tissue- and cell-type specific manner and play important roles in many molec-
ular and biological processes, including proliferation, apoptosis, development, and
differentiation[12, 42, 43, 44]. During adipogenesis, microRNAs are modulating the
formation and function of adipose tissue from various aspects. microRNA-33a and
microRNA-33b target genes are related to metabolism [45, 46] and microRNA-103,
and microRNA-107 regulate insulin sensitivity and glucose homeostasis by modu-
lating the abundance of caveolin-1 in adipocytes [47, 48]. Furthermore, microRNAs
have been associated with inflammation, oxidative stress, impaired adipogenesis and
insulin signaling, and apoptosis and angiogenesis in relation to obesity. All of these
processes contribute to the development of type 2 diabetes, atherosclerosis, and as-
sociated cardiovascular disorders [30, 41, 49, 50, 51]. However, their association
with these processes does not necessarily imply a causal role. Each microRNA can
have different roles in various conditions. For instance, microRNA-17-92 cluster,
microRNA-21, microRNA-103, miR-143, microRNA-371, and miR-378/378* have
shown to increase adipogenesis [47, 48, 52, 53, 54, 55, 56, 57]. This is evidenced
by increased concentrations of triglycerides in circulation and enhanced expression
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of adipogenic markers [33, 52, 54, 56, 57]. The microRNA-17-92 cluster induces
and accelerates adipocyte differentiation by suppressing expression of the pivotal
cell cycle regulator Retinobalstoma2 (Rb2/p130) [52]. In addition, let-7, microRNA-
27, microRNA-130, microRNA-138, microRNA- 369-5p, and microRNA-448 inhibit
adipogenesis which results in a decrease in triglycerides and down-regulation of
adipogenic factors [53, 58, 59, 60]. Similarly, microRNA-21 stalls adipogenesis by
inhibiting the Transforming Growth Factor beta (TGF-β) signaling pathway and
microRNA-143 acts in a similar fashion through down-regulating ERK-5 function
[54]. The let-7 microRNA inhibits adipogenesis by targeting high-mobility group AT-
hook 2 (HMGA-2)[53], whereas microRNA-27 and microRNA-130 functions through
suppressing peroxisome proliferator activated receptor γ directly [61, 62].
1.4 Significance of MicroRNAs in Regulating Adipose Tissue Macrophage
Activation
MicroRNAs are now accepted as important posttranscriptional regulators of gene
expression in immune cells like monocytes and macrophages [12, 13]. Varieties
of inflammatory signals stimulate microRNA expression induction like LPS, Tu-
mor Necrosis factor alpha (TNFα) or IL-1β and these tunes down TLR4/IL-1R
signaling pathways in macrophages/monocytes [12, 13]. A decrease in microRNA-
17, microRNA-92a and microRNA-155 is associated with an increase in monocyte/
macrophage proliferation and enhanced TLR-4 activation [63, 64, 65]. Similarly,
microRNA-424 expression in endothelial cells is increased from hypoxia and switches
pathway to regulate monocyte/macrophage differentiation [66, 67]. For example,
different studies have shown that microRNA-146, microRNA-125b, microRNA-155
and microRNA-9 are induced by LPS and subsequently inhibiting TLR4/IL-1R sig-
naling pathway by posttranscriptional regulation of the pathway components levels
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[68, 69, 70, 71]. In a similar fashion, some studies suggested microRNAs can directly
regulate production of type 2 cytokine productions during macrophage activation,
for example, microRNA-98 and microRNA-21 can control the expression of IL-10 in
macrophages and monocytes that in turn inhibit induction of expression of inflamma-
tory genes [60, 72]. Recent study found that let-7c regulates bactericidal and phago-
cytic activities of macrophages, two functional phenotypes implicated in macrophage
polarization [29]. Based on these evidences, it may be hypothesized that, in the con-
text of obesity, the switching of inflammatory macrophages to an anti-inflammatory
phenotype could be promoted by microRNAs. A study by Zhuang et.al identified
that microRNA-223 acts as an important regulator of ATMs polarization and fur-
ther demonstrated that it plays a significant role in modulating obesity associated
insulin resistance [28]. microRNA-223 is differentially expressed during macrophage
polarization, and microRNA-223deficient macrophages were hypersensitive to LPS
stimulation and exhibited delayed responses to IL-4 compared with controls. Fur-
thermore, there is an increase in M1 and decrease in M2 polarization biomarkers in
microRNA-223 deficient macrophages indicated suppressive effects on activation of
pro-inflammatory macrophages and a stimulatory effect on anti-inflammatory activa-
tion. microRNA-223deficient mice displayed enhanced adipose tissue inflammatory
responses and decreased adipose tissue insulin signaling accompanied by inappropri-
ate adipokine expression, which are indicators for adipose tissue dysfunction. These
results support the hypothesis that microRNA-223regulated macrophage polariza-
tion, likely acting through suppressing a pro-inflammatory gene Pknox1, is important
for adipose tissue function. These studies provided profound knowledge in a complex
interaction in the macrophage-mediated adipose tissue inflammatory responses and
metabolic regulation as well as indicating the possibility of targeting microRNAs
for treatment of metabolic disorders and disease resulting from insulin resistance.
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These are excerpts from the review that was published in Journal of Nutrition and
Food Sciences collectively signified the importance of microRNAs in diverse roles
of macrophage polarization with specific focus on the dysfunction of adipose tissue
and its disorders. Impairment in the normal functioning of adipocytes leads to an
inflammatory phenotype, with enhanced expression of pro-inflammatory adipocy-
tokines and down regulation of expression of anti-inflammatory adipocytokines. The
roles played by polarized macrophages are immense, and the significant contribution
by microRNAs could not be ignored as well.
1.5 Transcriptional Profiling of Macrophage Polarization
ATMs are major inflammatory mediators in white adipose tissue (WAT) of obese
individuals. Increased levels of chemokines secreted from adipose tissues recruit
circulating macrophages and other immune cells into fat depots of obese individu-
als [12]. ATMs display heterogeneous activation statuses that are associated with
various functions. Classic (M1) activation of ATMs leads to the production of pro-
inflammatory cytokines such as TNF-α, IL-1β, and IL-6; whereas alternative ac-
tivated macrophages (M2) produce anti-inflammatory cytokines such as IL-10 and
IL-13 [3]. In adipose tissue of the obese individuals, macrophages mainly display pro-
inflammatory M1 responses that contribute to systemic insulin resistance [23]. Clin-
ical studies suggest that the anti-inflammatory treatments can benefit patients with
systemic insulin resistance [5]. However, major questions related to how macrophage
polarized activation is regulated remain unanswered. To unveil the mechanisms un-
derlying polarized activation of macrophages, it is necessary to generate transcrip-
tome profiles so that valuable information can be extracted to depict the crosstalk
of signaling pathways that controlling ATM responses to various stimuli. This is the
major goal of my research. We adopted RNA-sequencing methodology to construct
9
total RNA libraries from macrophages in M0, M1, and M2 status. RNA sequenc-
ing datasets analysis revealed that several genes are differentially expressed, and
signaling pathways are altered during macrophage polarization.
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2. MATERIALS AND METHODS
2.1 Bone Marrow Isolation and Macrophage Differentiation
Protocols used for generation of Bone marrowderived macrophages (BMDMs)
were similar to previously described [28]. In brief, bone marrow cells from wild
type (WT) mice (C57Bl6) were collected. They were then treated with ammonium
chloride (Stem Cell Technologies) for erythrocyte lysis, and then seeded in 100 mm
plates at a concentration of 2x106 cells per 1 mL. Differentiation to monocytes of cells
was done with Iscoves Modified Dulbeccos Media (IMDM) medium having 10% Fetal
Bovine Serum (FBS) and 15% L929 culture supernatant for 7 days. The medium
was replaced on Day 3. Using flow cytometry, the generation of mature monocytes
was assessed on day 7 with fluorescence-conjugated antibodies against CD11b and
F4/80 [Fig 2.1a and b].
2.2 Macrophage Polarization
BMDMs were induced by lipopolysaccharide (LPS; 100 ng/mL) and Interferon
gamma (IFNG; 10ng/ml) or interleukin (IL-4) (10 ng/mL) and IL13 (10ng/ml) to
evaluate macrophage polarization. Using flow cytometry, surface antigens, CD69,
CD80, and CD86, were observed at 24 hours after stimulation [28]. Total RNAs were
extracted from these activated BMDMs at the similar time points and subjected to
gene expression study.
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Figure 2.1: Experimental Design for In-vitro Macrophage Polarization(A). Bone mar-
row cells are isolated and cultured for 7 days in the presence of M-CSF. Mature
macrophages are them subjected for stimulation with LPS and IFN-g for M1 and
IL4 and IL13 for M2. Macrophage maturation was evaluated using flow cytometry
(B). Total RNAs were extracted from activated macrophages and subjected to RNA
seq analysis.
2.3 Next Generation Sequencing Data Processing
Equal amounts of RNA from LPS and IFNg treated (M1), IL4 and IL13 treated
(M2) and untreated Macrophages (M0) from 5 sets of mice were pooled and the sam-
ples were used for high throughput RNA sequencing[Fig 2.2]. A total of 120 million
with 40 bps single-end Illumina reads were obtained from a multiplexing run on a sin-
gle lane. Reads filtered for adapter sequences and trimmed based on sequence qual-
ity (threshold of Q20) using ea-utils toolkit (https://code.google.com/p/ea-utils/).
Filtered reads less than 40 bps in length was discarded. Spliced alignment was per-
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Figure 2.2: RNA-Sequencing.Briefly, long RNAs are first regenerated into a library
of cDNA fragments through either RNA fragmentation or DNA fragmentation. Se-
quencing adaptors (dark blue) are later on attached to each cDNA fragment and
using high-throughput sequencing technology, a short sequence is generated from
each cDNA.
formed against the mouse genome mus-musculus 10 (mm10) using tophat2 (TopHat
2.0.10) without allowing any mismatches to reduce the number of false positives and
the resultant alignments were further processed using cufflinks2 (Cufflinks 2.2.1) to
perform reference annotation based transcript assembly with bias and multi-read
correction.
Differential expression analyses were performed using cuffdiff2, and the pictorial
representation of it was achieved through cummeRbund (CummeRbund 2.6.1). Out-
put data from tophat and cufflinks were converted to browser extensible data (BED)
13
files for viewing in the UCSC genome browser.
2.4 Gene Ontology Analyses
Functional enrichment analysis was executed using Ingenuity Pathway Analysis
(IPA) version 2.0 software (Ingenuity Systems Inc., Redwood City, CA). To perform
IPA analysis, all expressed genes (Fragments Per Kilobase Of Exon Model Per Million
Mapped Reads (FPKM) ≥ 0.05) in M0, M1and M2 were uploaded into three columns
for purpose of generating illumina probe Id and a column core analyses was performed
on each dataset. As the next step, for the purpose of performing a comparison core
analysis, all differentially expressed genes (fold change of 2) in M1vsM0, M2vsM0
and M1vsM2 were uploaded separately along with FPKM values and log fold change
values and analyses were done. By convention, genes that were up-regulated in each
dataset are shown in red and genes that were down-regulated are shown in green.
During IPA analysis, by default, the molecules present in the dataset and associated
with the Ingenuity Knowledge Base repository (Ingenuity Systems Inc.) were only
considered. The biological functions and diseases that were most important to the
dataset were identified using Functional Analysis. The significance of the association
with the dataset and the specific pathways of interest were determined in three ways:
(1) the activation z-score infers the activation state (Decreased or Increased), (2) a
P value was calculated using Fisher’s exact test which determines the probability of
the association between the genes in the pathway of interest and the dataset could
be explained by chance alone, and (3) ratio of the number of molecules in the dataset
that mapped to the pathway to that of the total number of molecules that linked
to the Ingenuity Knowledge Base pathway. Based on relationships in the molecular
network, he derivations of the z-scores are calculated which represent observed causal
associations in experiments between genes and those functions. Canonical pathway
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study was used to identify networks that are present in the IPA library which were
most significantly moderated across anatomical sites. Significance of the relationship
between each dataset and the canonical pathway was evaluated in 2 ways: (1) a P
value was calculated using Fisher’s exact test which determines the probability that
the association between the genes in the pathway of interest and the dataset could
be explained by chance alone, and (2) ratio of the number of molecules in the dataset
that mapped to the pathway to that of the total number of molecules that linked to
the canonical pathway.
2.5 RT-qPCR
The total RNA from the isolated cells was extracted using Trizol extraction pro-
tocol according to the manufacturers instructions. For gene expression analysis, ac-
cording to the manufactures protocol, quantitative RT-PCR (qPCR) was performed
with iScript One-Step RT-PCR kit with SYBR Green (Bio-Rad) on Bio-Rad CFX384
(Bio-Rad). Gene specific primer pairs were used. The data obtained represents the
mean of 2-δδCt from at least three independent experimental repeats. Beta-actin
reference gene was used for normalization [28].
2.6 Data and Statistical Analyses
Tukey post-test and One-way ANOVA were used to analyzed the dataset for
each factor at individual times. Each data point represents an average of 3 technical
replicates and presented as the meanSEM. Graphpad Prism version 5.01 software
was used to perform the data analysis [28]. P ≤ 0.05 was considered statistically
significant.
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3. RESULT AND DISCUSSION
3.1 Transcriptomic Analyses Revealed Almost Similar Number of Gene Expression
Our aim was to compare the transcriptomic expression profile of different acti-
vation states of macrophages. Accordingly, M0, the unactivated macrophages, and
the two activated states Classical M1 and alternate M2 states were chosen. Total
RNA was collected from these samples. The RNA sequencing of these samples was
performed using the Illumina platform, generating total 40 million high-quality raw
reads for each sample. The reads were aligned against the Ref-Seq mGRC38 (mouse
Genome Reference Consortium 38) mm10 reference [Table 3.1] genome using TopHat.
Cufflinks, a well-established transcript assembler, was used to perform the reference
genome-guided transcript assembly of the aligned reads. Based on the abundance of
the transcripts and their overall relative abundances that were expressed in all three
types of macrophages on each chromosome were binned and were compared using
cuffdiff.
Table 3.1: MM10 Reference Database: GRCm38 (C57Bl/6J). mm10 Database was
constructed by Genome Reference Consortium in 2012. It includes all 22 chromo-
somes. There are total 31805 transcripts which includes mRNAs, non coding RNAs
and also isoforms.
The assembled transcripts and their abundances were used to perform the fol-
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Table 3.2: 95% of RNA Sequencing Reads Mapped. RNA-seq reads obtained are
first filtered to filter out the shorter reads of less than 40bp in length, repetitive
sequences and others.
lowing statistical and secondary analyses. The transcripts that were differentially
expressed among the three macrophage groups and the pairwise comparison of all
3 individual samples were identified using cuffdiff. The statistical analysis is done
using the square root of the Jensen-Shannon divergence computed on the relative
abundances of the coding sequences, and the significance of differential expression
was based on uncorrected P-value and Benjamini-Hochberg correction for multiple-
testing.
Among the 40 million high quality single end raw reads for each sample, 95.06%,
95.43% and 95.21% of the reads were mapped [Table 3.2] to the mouse genome
mGRC38 for M0, M1 and M2 respectively. In each of the sample, the aligned reads
supported an average of 31800 transcripts including isoforms, mRNAs and non- cod-
ing RNAs (p value and FDR less than 0.05) that were identical to previously anno-
tated mm10 database.
Interestingly, average of 23434 distinct gene loci per sample was detected, indi-
cating the diversity introduced by isoforms of various genes. From the total of 3
sequenced samples, approximately 94000 known transcripts were identified, compris-
ing 69012 and 26403 genes and isoforms, respectively [Fig 3.1].
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Figure 3.1: RNA-Seq Bioinformatics Analysis Workflow
With all of our sequence reads, we assessed the expression levels of genes in M0,
M1 and M2 samples. Expression levels are measured in fragments per kilobase of
exon model per million mapped reads (FPKM), and the sum of the FPKM values
of its isoforms defines the expression level for a gene. Volcano plot showed the
distribution of gene expression values is left-skewed [Fig 3.2a]; the median and mean
FPKM values for M0 are 0.54836 and 34.11, respectively. Median and mean for M1
(0.5377, 45.7966) and M2(0.57498, 35.253) respectively showed the three datasets
have approximately similar median.
In order to avoid all the transcripts with FPKM values that are very close to 0,
we set the lower bound of 0.05 as an FPKM value in our subsequent analyses. Using
this criterion, we detected 14353, 14389 and 14358 transcripts expressed in our M0,
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M1 and M2 cells [Table 3.3].
Figure 3.2: Intensity and Total Number of Expressed Genes are Comparable in
Macrophages at Various Activation Status. The gene expression among M0, M1 and
M2. Density plot shows that most of the genes are expressed between 0.5 and 2
value of log10(FPKM). More number of genes are expressed in M2 in the range of
0.75 to 1.5 log10(FPKM). Box plot showing distribution of the expression profiles of
the three differently activated macrophages. Each box is based on 24000 genes based
on their FPKM values. Median FPKM values are denoted by black solid lines and
the top and bottom box edges denote the first and third quartile of FPKM values
comprising genes. Whiskers represents the largest and smallest data within 1.5 times
that of the interquartile range of FPKM.
Table 3.3: Genes are Considered Expressed with FPKM Value Greater than 0.05. In
the three datasets, approximately 14000 genes expressed.
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The transcript abundance was calculated based on the FPKM, and all expressed
transcripts were further binned on the basis of their abundance (FPKM). Based on
these grouping, it was revealed that the majority of the assembled transcripts were
low in abundance, i.e., below 10 FPKM. We classified genes into groups based on
their FPKM values: Not expressed (FPKM < 0.05), low expressed (0.05 ≤ FPKM
< 10), medium expression (10≤ FPKM < 100), and high expression (FPKM ≥ 100)
[Fig 3.3].
Figure 3.3: Distribution of Expression Pattern of Genes Based on FPKM. Classified
genes into groups based on their FPKM values- Not expressed (FPKM < 0.05), low
expressed (0.05 ≤ FPKM < 10), medium expression (10 ≤ FPKM < 100), and high
expression (FPKM ≥ 100).
In general, the transcripts expressed were higher in M2 than in the other two
groups. However, the overall number of transcripts and their expression profile in all
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three macrophages followed a similar trend [Fig 3.2b]. In agreement with the Box
plots, MA plots also showed similar outliers and similar expression pattern in all the
three samples [Fig 3.4a,b and c].
Figure 3.4: MA Plot Visualizing the Values of M1, M2 and M0 Genes Compared
to Each Other.Log10(M1/M0) indicates the fold-changes in the abundances of an-
notated genes between the two samples; (log2(M0)+log2(M1))/2 shows the average
abundance of an annotated genes.
Together, these analyses demonstrate the deviation in individual transcript ex-
pression levels, which is probably due to a great number of low abundance transcripts
in all of the samples, an occurrence generally witnessed in RNA sequencing data
studies.
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Figure 3.5: Cluster Analysis of Differentially Expressed Genes. Macrophage polar-
ization related gene expression is summarized from profiles in M1 or M2 comparing
to M0. A total of 1934 genes were upregulated and 1664 downregulated in M1 vs
M2.
3.2 M1 Vs M2 Macrophages Have More Number of Differentially Expressed Genes
To estimate the differentially expressed genes and transcripts between the three
macrophage groups, we set fold change of 2 as a lower bound for our subsequent
analyses [Fig 3.5] [Table 3.4]. We identified 3010 transcripts that were differentially
expressed between the M1 and M0 groups. Among the identified transcripts, 1556
transcripts exhibited a higher abundance (up-regulated) in the M1 group, and 1454
manifested lower relative abundance (down-regulated) than in the M0. When the
M2 group was compared with the M0 group, 1011 transcripts were identified as
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differentially expressed. Among these transcripts, 611 were up-regulated, and 400
down-regulated in M2. The M1 and the M2 group comparison revealed 2256 tran-
scripts that were differentially expressed and 1027 transcripts were up-regulated and
1229 down-regulated in M1.
Table 3.4: Differentially Expressed Genes Among M0, M1 and M2.Genes are con-
sidered differentially expressed with log2 fold change value greater than 1 or less
than -1. It is found that there are around 1300 differentially expressed genes in M2
compared to M0. 2400 genes were differentially expressed in M1 vs M0. About 1900
genes were highly expressed in M1 compared to M2 and around 1600 genes were
under expressed in M1 compared to M2.
The comparative analyses of these three samples at gene level [Fig 3.6] provide
a complete view of the whole transcriptomic changes among the three groups. To
further explore the pairwise relationship, regression plots were constructed which
explain that M2vsM0 have R-Square value of 0.95 when compared to 0.90 and 0.91
for M1vsM0 and M1vsM2 plots [Fig 3.7].
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Figure 3.6: Differentially Expressed Genes Among M0, M1 and M2 Macrophages.
Shown is a Volcano plot comparing the normalized expression of gene probe sets
of macrophage polarization. Each red dot indicates a gene with more than 2-fold
change and p-value less than 0.01 comparing to M0. Macrophage polarization related
gene expression is summarized from profiles in M1 or M2 comparing to M0. A total
of 1934 genes were up-regulated and 1664 down-regulated in M1 vs M2.
Figure 3.7: Regression Profiles Signify That M2 and M0 Macrophages Have a Very
High R Square Values
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There are plenty of mRNAs that are differentially expressed between M1 and M2
when compared to M0 [Fig 3.8 and Table 3.5]. Certain genes related to Antigen
presentation and Processing, P53 signaling pathways, pro-inflammatory pathways
have found to be highly expressed in M1 compared to M2. Whereas genes that a
play role in anti-inflammatory pathways, focal adhesion and Extracellular Matrix
(ECM) interaction pathways were abundantly expressed in M2 samples. This was
much evidently proved by Gene Ontology (GO) studies as well.
Figure 3.8: Cluster Analysis of Differentially Expressed mRNAs. Macrophage po-
larization related mRNAs expression is summarized from profiles in M1 or M2 com-
paring to M0. Several mRNAs are distinctly differentially expressed among the two
groups.
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Moreover, the differential expression of transcripts that resulted in more than one
assessment were separated from the bona-fide transcripts that were specific to one
comparison, i.e., the transcripts specific for M1 vs. M0 (3413 genes, 3010 mRNAs),
M2 vs. M0 (1011 mRNAs, 1286 genes) and M1 vs. M2 (2256 mRNAs, 3598 genes)
[Fig 3.9 and Table 3.6].
Figure 3.9: Analysis of Protein Coding Genes. Box plot showing distribution of the
expression profiles of the three differently activated macrophages. Each box is based
on 24000 genes based on their FPKM values. Median FPKM values are denoted by
black solid lines and the top and bottom box edges denote the first and third quartile
of FPKM values comprising genes. Whiskers represents the largest and smallest data
within 1.5 times that of the interquartile range of FPKM.
Table 3.5: Analysis of Protein Coding Genes.Most of the genes expressed are protein
coding genes.
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Table 3.6: Differential Expression Pattern of mRNAs: It is found that there are
around1000 differentially expressed mRNAs in M2 compared to M0. 2000 mRNAs
were differentially expressed in M1 vs M0. About 1027 mRNAs were highly ex-
pressed in M1 compared to M2 and around 1229 mRNAs were under expressed in
M1 compared to M2.
Interestingly, when we compared the abundantly expressed genes in all M0, M1
and M2 (FPKMM≥100), it was revealed that 703 transcripts were highly expressed
in all three samples.
It signifies that these genes could be responsible for the basic physiological func-
tions of all the macrophages. 245 genes were abundantly expressed in M1 alone
compared to 54 and 22 in M2 and M0 [Fig 3.10].
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Figure 3.10: Genes Expressed More than 100 FPKM. Three sets of macrophage
profiles comparing M1, M2 and M0 samples were analyzed to identify genes which
are consistently upregulated (FPKM ≥ 100). Analysis revealed that 703 genes are
highly expressed (FPKM ≥ 100) in all M0, M1 and M2 samples and 22, 245 and 54
are uniquely highly expressed (FPKM ≥ 100) in M0, M1 and M2.
Figure 3.11: Validation of RNA Seq Data for Certain Genes Using qPCR. Expression
levels of PTGS2 was found to be significantly higher in m1 compared to M0 and M2.
Il10, IL1b, CDK2 and CEBPb all follow the similar expression pattern as the data
sets of RNA-seq revealed.
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We further did a qPCR analysis of certain transcripts in all the three groups M0,
M1 and M2. These observations indicate the accuracy of the RNA sequencing-based
transcript reconstruction and abundance calculation (Fig 3.11).
3.3 Crosstalk Between Signaling Pathways
To associate cellular functions with the set of differentially expressed genes, we
used DAVID Gene Ontology program and Ingenuity pathway analysis. Gene net-
works were assessed using the IPA library of canonical pathways. Specifically for
transcriptional data, the genes that were differentially expressed with at least 2-fold
enriched occupancy of M1 and M2 compared to M0 were associated with canonical
pathways using the Ingenuity Knowledge Base. Using this approach, the top canoni-
cal pathways that were found to be affected by the genes which are highly expressed
in M1 compared to M0 are Dendritic cell Maturation, Graft versus Host Disease
Signaling, Trem1 signaling and Type 1 Diabetes Mellitus [Fig 3.12].
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Figure 3.12: Gene Ontology analysis for Genes with More than 2 Folds Alteration
During Macrophage Polarization. Cellular functions of significantly altered genes
in M1 or M2 are analyzed. In M1 macrophages, several GO terms are significant
enriched (P≤ 0.001) including Type I Diabetes mellitus and Antigen Presenting and
Processing; whereas ECM receptor interaction is highly enriched in M2
This is noteworthy, because these canonical pathways are involved in all aspects
of known M1 macrophages. In upstream regulator analyses, we found that MYD88
(Myeloid differentiation Primary response 88), TICAM1 (Toll - Like Receptor Adap-
tor Molecule1), IFNG, SOCS1 (Suppressor of Cytokine Signaling1) and IFNB1 are
the top regulators in M1 compared to M0 [Table 3.7a,b and c]. Genes highly ex-
pressed in M1 datasets are also involved in some of the important disease and disor-
ders including infectious disease, immunological disease, and gastrointestinal disease
to name few. We next identified those biological functions most significantly asso-
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ciated with the M1 RNA-Seq datasets using the IPA Functional Analysis feature.
Table 3.7: M1 IPA Analyses. IPA analyses of the genes expressed in M1 showed that
TLR4, IFNg, Stat1 are some of the top upstream regulators for the different func-
tional pathways the genes expressed in M1 are involved. IFNg is found to play role in
antigen presentation and processing, allograft rejection signaling pathway and these
pathways found their position in the top KEGG terms. Right-tailed Fishers exact
test was used to calculate p-values determining the probability that each biological
function was due to chance alone.
This highlighted that inflammatory response genes were the top biological func-
tion comprising of about 109 genes. David Gene Ontology studies revealed that genes
which are highly expressed in M1 when compared to M0 enriched KEGG (Kyoto
Encyclopedia of Genes and Genomes) terms like Type I Diabetes mellitus, Antigen
Presentation and Processing, Pathways in cancer to highlight few. On the other
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hand, KEGG terms enriched by genes highly expressed in M2 when compared to M0
include Focal adhesion, calcium signaling pathway, and ECM receptor interaction to
name some [Fig 3.13].
Figure 3.13: Significantly Enriched GO Terms in M1 or M2 Activation. The fold
enrichment of the KEGG terms was analysed and was found that with the genes dif-
ferentially expressed in M1 some of the key KEGG terms with high fold enrichment
includes Antigen Presentation and Processing, Type I Diabetes mellitus, Adipocy-
tokine signaling pathway and others. Whereas the differentially expressed genes in
M2 are found to have KEGG terms with high fold enrichment like ECM-receptor
interaction, Calcium Signaling and others.
Using IPA, when M2 datasets were analyzed, it revealed that miR-223 is one
of the top upstream regulators among other significant regulators like IL4, IGF1r
(Insulin Growth Factor 1 receptor), CCR2 (Chemokine (C-C Motif) Receptor 2)
and others [Table 3.8a].
Role of miR-223 was significantly proved in previous research studies of our lab
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Table 3.8: M2 IPA Analyses.IPA analyses of the genes expressed in M2 showed
that miR223, IL4, IGF1r are some of the top upstream regulators for the different
functional pathways the genes expressed in M2 are involved. B cell receptor signaling,
protein ubiquitination pathway, molecular mechanisms of cancer found their position
in the top KEGG terms. Right-tailed Fishers exact test was used to calculate p-values
determining the probability that each biological function was due to chance alone.
[28]. Mir-223 is known to up-regulate expression of Ataxia Telangiectasia, NFIA
(Nuclear factor I/A), SLC2A4 (Solute Carrier Family 2, member 4) and others. It is
also found to down-regulate genes including STAT3 (Signal Transducer and Activator
of Transcription 3), FBXW7, IGF1R and many more. Interesting knock down mir-
223 studies showed that it also reduces the expression levels of IGF1, TLR13 (Toll
Like Receptor13), and TGFb1 to name some [Fig 3.14].
Studies on mir-223 have shown that it inhibits nuclear translocation of STAT3 in
glomerular endothelial cells. STAT3 is a very important transcription factor involved
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in regulation of transcription of a variety of genes in response to cell stimuli, and thus
plays a key role in many cellular processes such as cell growth and apoptosis [73].
Genes highly expressed in M2 datasets are found to be involved in different canoni-
cal pathways including B cell receptor signaling, Glucocorticoid signaling, Molecular
mechanisms of cancer and lot more[Table 3.8b]. Macrophages activate to M2 status
are also involved in different disease and disorder conditions including cancer, in-
fectious disease, immunological disease, hematological disease and many more[Table
3.8c].
Figure 3.14: MiR223 Regulates Different Genes Which Impact Various Functional
Pathways. miR223 decreases the expression of STAT3 and IGF1r. STAT3 is a very
important transcription factor involved in regulation of transcription of a range of
genes in reaction to cell stimuli, and thus is involved in many cellular developments
such as cell growth and apoptosis. Knockdown of miR-223 decreased expression of
Tlr13, TGFb1, IGF1, Ly96 and others highlighted with blue arrow.
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3.4 Role of M1 in Diabetes Type I Mellitus is Signified by High Expression of
PPARG and IGF2bp2
IPA analysis revealed that classically activated macrophages have genes with high
expression that are involved in Diabetes mellitus. Some of the notable genes are
Pparg (Peroxisome Proliferator-Activated Receptor),FTO (Fat Mass and Obesity
Associated),Kcnj11 (Potassium Inwardly-Rectifying Channel, Subfamily J, Mem-
ber 11), Notch2,Wfs1 (Wolfram Syndrome 1),Igf2bp2,Slc30a8,Jazf1 (Jazf Zinc Fin-
ger 1),Hhex (Hematopoietically Expressed Homeobox),Cdkal1,Cdkn2a,Capn10 (Cal-
patin 10) and the research team of Shukui Wang identified two additional genes
Rapgef(Rap Guanine Nucleotide Exchange Factor) andTp53 (Tumor protein 53) re-
lated to type 2 diabetes risk. The authors suggest that Rapgefrepresents a strong
candidate because of its role in insulin signaling. In addition, theRapgefpathway may
be involved in the regulation of proglucagon gene expression in intestinal endocrine
L-cells [74], providing another mechanism for its effect on risk of type 2 diabetes.
Rapgef is very highly expressed in M1 when compared to M2 and M0. Other genes
like Pparg and Igf2bp2 are also very highly expressed in M1. Pparg is very well
known for its involvement in inducing adipogenesis and its over expression also in-
creases insulin sensitivity that is of great benefit in diabetes treatments [75]. Igf2bp2
is insulin like growth factor-2 protein which play a vital role in the regulation of
Insulin Growth Factor2 expression. IGF2B2 functions by binding to 5’UTR of the
IGF2 mRNA and regulates IGF2 translation.
3.5 High Expression of CIITA and TAP Genes Shows Role of M1 in Antigen
Presentation Pathway
Of the many different genes that are involved in antigen presentation pathway,
Some genes like CD74, CIITA (Class II, Major Histocompatibility Complex, Trans-
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activator), IFNG, PSM8 and 9, TAP1 (Transporter 1, ATP-Binding Cassette) and
2 and TAPBP are very highly expressed. CD74 is related with class II major histo-
compatibility complex (MHC) and is an significant chaperone that controls antigen
presentation for immune response [76]. Studies also revealed that It serves as cell sur-
face receptor for the cytokine macrophage migration inhibitory factor (MIF) which
initiates survival pathways and cell proliferation when bound to the encoded protein
[77]. TAP 1 and 2 are the one that hold the peptide fragments and transport it to the
endoplasmic reticulum from the cytoplasm [74]. CIITA is responsible for activation
of MHC1 and II to which CLIP protein binds and aids in the transport of peptide
fragment from ER to Golgi and then to late endosome. IFNG is very much involved
in activation of TAP1 and 2 and making them bind to the peptide fragments. It also
activates CIITA and NLRC5, which are involved in transport of peptide fragments
[78]. The expression levels of these genes in M1 signified their role in antigen presen-
tation. TAP1 and TAP2 expression levels are significantly higher in M1 with FPKM
about 331 and 343 compared to 146.1 and 94.8 in M0 respectively. High CD74 ex-
pression levels of 2228.3 in M1 compared to 713.29 in M0 reveals that classically
activated macrophages are involved in antigen presentation and processing.
3.6 Genes Related to Atherosclerosis Signaling are Highly Expressed in M2
IPA analysis revealed that alternatively activated macrophages have genes with
high expression that are involved in atherosclerosis signaling. Some of the notable
genes are involved in diabetic atherosclerosis are Ager, collagen, MMP2 (Matrix Met-
allopeptidase2), MMP9, NFKB1 (Nuclear Factor of kappa light polypeptide gene en-
hancer in B-cells), PTGS2 and RELA. Of these, MMP9, NFKB1 and PTGS2 genes
are very highly expressed signifying the role of alternate activated macrophages in
atherosclerosis. In atherosclerosis signaling, triggering of CCR2 by Low Density
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Lipoprotein (LDL) leads to monocyte-endothelial cell adhesion via ICAM-1 and
VCAM-1. MCP1 mediated transendothelial migration of monocytes into intima
is followed [79]. M-CSF produced by endothelial cells differentiates monocytes to
macrophages. In these macrophages, uptake of oxidized LDL via scavenger recep-
tors leads to lipid accumulation and foam cell formation. In foam cells, the tumor
necrosis factor receptor is activated by a ligand, which increases the expression of
IL6, IL8, MCP1 and NFKB1 to further activate MMP9 [80]. MMP proteins act on
the collagen released from the smooth muscle cells. M2 macrophages are also very
much involved in anti-inflammatory signaling and other processes.
3.7 Regulation of Expression by IFN-Gamma Play Important Role in Allograft
Rejection and Antigen Presentation
IFN-gamma plays a significant role in different functional roles. It binds to
IFNGR1, STAT receptors, JUN, CREB (Camp Responsive Element Binding Pro-
tein), NFAT (Nuclear Factor Of Activated T-Cells) and other, and regulates certain
genes like NOS2, IRF1, STAT1, CXCL10, TNF, ICAM1, MHC classII which are
involved in some of the important functional pathways involving antigen presenting
pathway, atherosclerosis signaling, allograft rejection signaling and others [Fig 3.15].
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Figure 3.15: IFNg- One of the Top Upstream Regulator. IFNg regulates expression
of several genes and further impact their role in different functional pathways. IFNg
plays a pivotal role in regulation of NFkB, Stat and TNF contributing to its role in
activation of macrophages. Some of the genes which are involved in differentiation
of macrophages are also regulated by IFNg.
In allograft rejection signaling pathway, IFN-G stimulates macrophages to pro-
duce NO and TNF-alpha, which play a role in cytotoxicity towards the donor cell
[81]. In our datasets, TNF expression levels in M1 macrophages (FPKM= 94.83) are
significantly higher when compared to the expression levels in M1 and M0 (FPKM
7.4 and 8.83). In antigen presentation pathway, IFN-G stimulates activation of CIIA
(MHC co-activator) and NLRC5 which further stimulates the MHCII to bind to the
peptide fragment and MHCI bind to the CLIP (Cap-Gly Domain Containing Linker
Protein) (CD74 MHCII variant) [77]. Supporting this the datasets also show expres-
sion levels of CIITA found FPKM value to be around 10.825 for M1 whereas in M2
and M0 it is expressed around 6.26 and 3.28 respectively. Also, NLRC5 expression
value is 87.27 whereas the expression levels in M2 and M0 are very less about 27.88
and 30.28 respectively.
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3.8 LPS Induces Genes Responsible for Cellular Immune and Humoral Response
LPS is an endotoxin protein and binds to certain receptors including TLR4, CD14,
APCS, ITGB2 and others and induces different immune related functional pathways
[74]. Binding of LPS to TLR stimulate production of IFN-Beta that play a role in
adaptive immune response [82]. Our dataset also clearly shows that the expression of
IFN-Beta was significantly enhanced to 29.97 in M1 when compared to 0.69 FPKM of
M0. In response to LPS, TLR also stimulates IL8 and IP10, which further took part
in chemo attraction of neutrophils, TH1 cells and monocytes [82]. In addition, TLR
also enhances MIP1 production that is involved in the chemoattraction of T cells
and dendritic cells. IL12 synthesis is also increased which further enhances IL10 and
IFNG, which further play a role in the development of humoral immune response and
development of cellular immune response respectively [83]. The enhanced expression
levels of IL10 and IFNG is also revealed in our datasets showing expression levels of
FPKM 15.94 and 13.67 in M1 compared to 4.63 and 2.42 in M0 respectively. LPS also
activates P38 MAPK and JNK through TLR that together enhance IL12-P40 playing
pivotal role in signaling and production of macrophages. IL12-P40 further activates
Il12-P80 which has roles in TH1 activation and inhibition, macrophage recruitment
and DTH [84]. LPS also has role in the production of nitric oxide and reactive
oxygen species. It triggers MIK and PI3K expression which in turn play a role in
the production of nitric oxide that is important for protection against infection and
neoplasia and inflammation ageing neurotoxicity [76]. Activation of Reactive oxygen
species plays a role in innate immune response against microbes.
3.9 IL4 Aids in THh1 Response
There are certain pathways and genes that are being induced by Interleukin-4.
IL4 is a very well-studied TH2 cytokine that is involved in induction and initiation
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of various functional pathways. IL4 binds to IL4R, IL2RG, Nfat, STAT6 and oth-
ers. These binding in turn regulate certain functional pathways including allograft
rejection, T helper cell differentiation, hematopoiesis from pluripotent stem cells and
other important functional roles. In allograft rejection signaling, IL4 induces B cells
which are bound by MHCII and CD40 which further aids in alloantibody graft re-
jection by producing IgG which further plays role in Complement aided damage by
action on MHCII [85]. In crosstalk between dendritic and natural killer cell, IL4
triggers the expression of DAP12 and TREM2 (Triggering Receptor Expressed On
Myeloid Cells 2). Trem2 further regulates the action of IFN-G [77]. In IL12 signal-
ing, IL4 induces STAT6 that will further inhibit the action of STAT4 on IFN-G that
is playing important role in TH1 response in intracellular bacterial death [79].IL4
also has an important part to play in hematopoiesis from pluripotent stem cells.
3.10 Genes and Pathways Induced Through IL13
IL13 induces many important functional pathways. It binds to IL13RA1, IL4R,
STAT6, CHD4, AP1 and others. It regulates ARG1, TNF, NOS2, TGFB1, STAT6,
CCL4 and these will further regulate crucial biological functions including differential
regulation of Cytokine production in Macrophages and T Helper cells by IL17, T
Helper cell differentiation, Role of cytokines in mediating communication between
immune cells.
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3.11 Interaction Between IL4, IL13 and IFNG
Figure 3.16: IFNG, IL4 and IL13 Interaction Pattern. IFNG, IL4 and IL13 have
different impacts on different genes. IL13 increases the expression of CASP1 whereas
IFNg down-regulates its expression. Casp1 play pivotal role in apoptosis. IFNg
decreases the expression levels of IRF1 but IL4 increases its expression. Ifng decreases
the expression of insulin growth factor 1 (IGF1) and also do have an effect on the
reducing effect of insulin. Il4 induction of macrophages induces the expression of
IGF1, correlating its effect on enhancing insulin sensitivity. Ifng stimulates the
expression of Interferon regulatory factor1 .
IL4 upregulates Pparg whereas Ifng downregulates it. Pparg that plays an im-
portant role in M2 activation and also in different physiological function in which M2
is involved are regulated through Il4 and Pparg as well. Ifng decreases the expression
of insulin growth factor 1 (IGF1) and also do have an effect on the reducing effect of
insulin. Il4 induction of macrophages induces the expression of IGF1, correlating its
effect on enhancing insulin sensitivity. Ifng stimulates the expression of Interferon
regulatory factor1 [Fig 3.16].
41
4. CONCLUSION AND FUTURE PROSPECTS
In summary, we have documented for the first time the gene expression profiles
for the macrophages in different activation states by correlating our data with qPCR.
Globally, approximately 3000 genes were differentially expressed among the M0, M1
and M2 states of macrophages. With regard to differentially expressed genes, a high
correlation was observed between M0 and M2 in RNA-Seq data. Gene ontology
analysis indicated abundantly expressed genes in M1 significantly impacted Type
I diabetes and antigen presentation and processing. On the other hand, focal ad-
hesion, ECM interaction signaling are influenced by genes highly expressed in M2.
Interestingly IFNG plays important role in functions related both to M1 and M2.
In conclusion, distinct combinatorial patterns of gene expression exist in classically
and alternate activated macrophages. These specific differences may explain the
differential effects of macrophages in its different roles. Future research could be
a profound understanding of the complex network of interactions among different
factors involved in state of polarization of macrophages in health and disease.
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